Disseminated Fusarium infection in a multiple trauma patient

Southern Medical Journal

Volumn 101, Issue 3, 2008, Pages 320-323

  Testerman, George M ^a   Steagald, Melinda K ^a   Colquitt, Landon A ^a   Maki, Anton ^a  

^a Wellmont Holston Valley Hospital Trauma Center   (United States)

Author keywords

Disseminated Fusarium; Immunosuppressed; Trauma; Voriconazole

Indexed keywords

VORICONAZOLE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FUSARIUM; HEMODIALYSIS; HUMAN; LABORATORY; MALE; MULTIPLE TRAUMA; MYCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING;

ACCIDENTS, TRAFFIC; ADULT; ALCOHOLISM; ANTIFUNGAL AGENTS; FATAL OUTCOME; FUSARIUM; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MULTIPLE TRAUMA; MYCOSES; SOFT TISSUE INFECTIONS; SUBSTANCE-RELATED DISORDERS; WOUND INFECTION;

EID: 41849112330     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318164e392     Document Type: Article

References (18)

1. Nucci M, Anaissie EJ. Emerging fungi. Infect Dis Clin N Am 2006;20:563-579.
2. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with haematological malignancy: ten years experience at a cancer centre and implications for management. Blood 1997;90:999.
3. Kauffman CA. Fusarium. Available at: http://www.uptodate.com. Accessed September 2007.
4. Martino P, Gastaldi R, Raccah R, et al. Clinical patterns of Fusarium infections in immunocompromised patients. J Infect 1994;28(suppl 1):7.
5. Enomoto M. Fungal toxins, in Braude AI, Davis CE, et al (eds): Infectious Diseases and Medical Microbiology. Philadelphia, Saunders, 1986, ed 2, p 131.
6. Guarro J, Nucci M, Akiti T, et al. Mixed infection caused by two species of Fusarium in a human immunodeficiency virus-positive patient. J Clin Microbiol 2000;38:3460.
7. Cho CT, Vats TS, Lowman JT, et al. Fusarium solani infection during treatment for acute leukemia. J Pediatr 1973;83:1028.
8. Wingard JR. The changing face of invasive fungal infections in hematopoietic cell transplant recipients. Curr Opin Oncol 2005;17:89.
9. Paugam A, Baixench MT, Frank N, et al. Localized oral Fusarium infection in an AIDS patient with malignant lymphoma. J Infect 1999;39:153.
10. Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect 2004;10(suppl 1):67.
11. Liakis MS, Kontoyiannis DP. Fusarium infections in critically ill patients. Semin Respir Crit Care Med 2004;25:159.
12. Smith M, McGinnis MR. Fusarium sporodochia on cutaneous wounds. Med Mycol 2005;43:83.
13. Latenser BA. Fusarium infections in burn patients: a case report and review of the literature. J Burn Care Rehabil 2003;24:285.
14. Venditti M, Micozzi, A, Gentile G, et al. Invasive Fusarium solani infections in patients with acute leukemia. Rev Infect Dis 1988;10:653.
15. Mays SR, Bogle MA, Bodey GP. Cutaneous fungal infections in the oncology patient: recognition and management. Am J Clin Dermatol 2006;7:31.
16. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002;34:7.
17. Perfect J. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 2003;36:1122.
18. Herbrecht R. Voriconazole: therapeutic review of a new azole antifungal. Expert Rev Anti Infect Ther 2004;2:485.